Today we're talking about "Clopidogrel Resistance ... And this is not good. The patients do not like it, and clearly we would need something else and maybe a different drug, which is what we ...

In this trial, the 7% relative risk reduction in all-cause mortality in patients treated with clopidogrel compared with those who were not is considerable, especially as this reduction in ...